InsiderTape plots every Form 4 on the price chart and flags cluster buys, CEO conviction, and first buys in years the moment they file. Start a free 7-day trial, cancel anytime.
START FREE TRIAL →Andrew Hollman Meyer, Chief Business Officer, is a corporate insider tracked by InsiderTape across 1 company. The public record shows 10 open-market SEC Form 4 transactions: 0 purchases worth $0 and 10 sales worth $3.7M, reported from Sep 27, 24 to Jan 2, 26. Over this period they have been a net seller.
| Date | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Jan 2, 26 | JANXJanux Therapeutics, Inc. | SELL | 1.9K | $13.73 | $26K |
| Dec 1, 25 | JANXJanux Therapeutics, Inc. | SELL | 2.7K | $33.52 | $89K |
| Nov 14, 25 | JANXJanux Therapeutics, Inc. | SELL | 3.3K | $30.00 | $100K |
| Oct 28, 25 | JANXJanux Therapeutics, Inc. | SELL | 16.7K | $30.06 | $501K |
| May 1, 25 | JANXJanux Therapeutics, Inc. | SELL | 2.9K | $32.60 | $94K |
| Apr 21, 25 | JANXJanux Therapeutics, Inc. | SELL | 3.3K | $30.00 | $100K |
| Mar 3, 25 | JANXJanux Therapeutics, Inc. | SELL | 2.4K | $32.85 | $78K |
| Feb 3, 25 | JANXJanux Therapeutics, Inc. | SELL | 2.4K | $43.60 | $102K |
| Jan 2, 25 | JANXJanux Therapeutics, Inc. | SELL | 5.8K | $57.37 | $314K |
| Sep 27, 24 | JANXJanux Therapeutics, Inc. | SELL | 50.0K | $45.96 | $2.3M |